ONCOLife Issues
Featured Articles
Trending Articles
TROPION-Breast01: Redefining Treatment for HR+/HER2– Metastatic Breast Cancer
ONCOLife | 18 June 2025
The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines
ONCOLife | 29 August 2025
Breaking the Molecular Link Between Alcohol and Pancreatic Cancer by Targeting CREB
Clinical Trials | 13 August 2025
PADCEV–KEYTRUDA Combination Delivers Survival Gains in High-Risk Bladder Cancer
ONCOLife | 12 August 2025
FDA Grants Fast Track Designation to Birelentinib for Relapsed/Refractory CLL and SLL
FDA & EMA | 9 August 2025
Epcoritamab + R2 Achieves 95.7% ORR, Cuts Risk by 79% in R/R Follicular Lymphoma
ONCOLife | 8 August 2025
Novel Viral Immunotherapy SuperNova Gains FDA Fast Track Designation for Sarcoma
FDA & EMA | 4 August 2025
FDA Fast-Tracks Breyanzi as First CAR T Cell Therapy for Marginal Zone Lymphoma
FDA & EMA | 5 August 2025
FDA Approves Modeyso as First-Ever Therapy for Pediatric Brain Tumor, H3 K27M+ Glioma
FDA & EMA | 6 August 2025
2025 Pan-Mass Challenge Draws Thousands of Cyclists to Fuel Next Era of Cancer Research
ONCOLife | 3 August 2025
Promising Results: Jaypirca Outperforms Imbruvica in Landmark Phase 3 CLL/SLL Trial
Clinical Trials
30 July 2025
Artificial Sweetener Sucralose May Undermine Cancer Immunotherapy, Study Finds
ONCOLife
31 July 2025
First Non-Invasive Endometrial Cancer Detection Test, EdenDx, Launched by Gnosis
ONCOLife
31 July 2025
Supercharging Chemotherapy with a Mitochondrial Strategy for Lung Cancer Treatment
ONCOLife
30 July 2025
A Mitochondrial Makeover: Rewiring T Cells to Supercharge Cancer Immunotherapy
ONCOLife
29 July 2025
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
ONCOLife
25 July 2025